Peter Guenter

2024-02-22T11:29:44-06:00February 21, 2024|

Peter Guenter is a member of the Executive Board of Merck and CEO of Healthcare. He joined Merck in January 2021. Before joining Merck, Guenter served as CEO of Spanish pharma company Almirall from 2017 to 2020. Prior to that, [...]

Scott White

2024-02-27T17:05:34-06:00February 20, 2024|

Scott White is Company Group Chairman, North America, at the Janssen Pharmaceutical Companies of Johnson & Johnson. A member of the Pharmaceuticals Group Operating Committee, he is responsible for leading Janssen’s efforts to transform the health of people in the [...]

Peter WT Pisters, MD, MHCM

2024-02-27T17:00:48-06:00February 20, 2024|

Peter WT Pisters, M.D., took the helm as president of The University of Texas MD Anderson Cancer Center in 2017, and forged a new path forward to end cancer by transforming the culture of the nation’s top-ranked cancer center. With a [...]

Norman “Ned” Sharpless, MD

2024-02-27T16:44:10-06:00February 20, 2024|

Dr. Sharpless led the National Cancer Institute (NCI) from 2017 to 2022. He was appointed acting commissioner of the U.S. Food and Drug Administration (FDA) in 2019 and served for seven months before returning to his position at the NCI. [...]

Major General Elder Granger, MD

2024-02-27T17:22:12-06:00February 20, 2024|

Since 2009, Major General Granger has been the President and CEO of THE 5Ps, LLC, a health care, education, and leadership consulting organization in Colorado. Prior to his retirement from the US Army in 2009, Dr. Granger served as the Deputy Director and [...]

John Crumpler

2024-02-27T17:21:46-06:00February 20, 2024|

John co-founded Hatteras in 2000 after a successful career as a technology entrepreneur. After a decade in politics and public policy, he was founder and CEO of E-Comm, Inc., a software development and services firm specializing in remote and mobile [...]

James Goodnight, PhD

2024-02-27T17:24:43-06:00February 20, 2024|

As the CEO of SAS, the world’s leading business analytics software vendor, Jim Goodnight has led the company since its inception in 1976, overseeing an unbroken chain of revenue growth and profitability unprecedented in the industry. He is recognized globally [...]

David M. Reese, MD

2024-02-27T15:41:58-06:00February 20, 2024|

Dr. David M. Reese is executive vice president, Research and Development. In this role, Dr. Reese oversees Discovery Research, Global Development, Global Regulatory Affairs and Safety, as well as Global Medical. Dr. Reese joined Amgen in 2005 and has served [...]

Christopher A. Viehbacher

2024-02-27T16:38:53-06:00February 20, 2024|

Mr. Christopher Viehbacher is president and CEO of Biogen, a multinational biotechology company. He is also a founding partner of Gurnet Point Capital, a Boston-based investment fund associated with the Bertarelli family with a $2 billion capital allocation. He is [...]

Go to Top